{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T21:40:03Z","timestamp":1739050803542,"version":"3.37.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,4,7]],"date-time":"2009-04-07T00:00:00Z","timestamp":1239062400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s12185-009-0292-7","type":"journal-article","created":{"date-parts":[[2009,4,6]],"date-time":"2009-04-06T04:02:08Z","timestamp":1238990528000},"page":"445-451","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy and prognosis of chronic myeloid leukemia treated with imatinib mesylate in a Chinese population"],"prefix":"10.1007","volume":"89","author":[{"given":"Yanmin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gongqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanzhuo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maofang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,4,7]]},"reference":[{"key":"292_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJM199909023411016","volume":"341","author":"I Nash","year":"1999","unstructured":"Nash I. Chronic myeloid leukemia. N Engl J Med. 1999;341:765. doi: 10.1056\/NEJM199909023411016 .","journal-title":"N Engl J Med."},{"key":"292_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1056\/NEJMoa011573","volume":"346","author":"H Kantarjian","year":"2002","unstructured":"Kantarjian H, Sawyers C, Hochhaus A, et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med. 2002;346:645\u201352. doi: 10.1056\/NEJMoa011573 .","journal-title":"N Engl J Med."},{"key":"292_CR3","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker BJ, Guilhot F, O\u2019Brien SG, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006;355:2408\u201317. doi: 10.1056\/NEJMoa062867 .","journal-title":"N Engl J Med."},{"key":"292_CR4","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/cncr.22498","volume":"109","author":"Z Aziz","year":"2007","unstructured":"Aziz Z, Iqbal J, Akram M, et al. Treatment of chronic myeloid leukemia in the imatinib era: perspective from a developing country. Cancer. 2007;109:1138\u201345. doi: 10.1002\/cncr.22498 .","journal-title":"Cancer."},{"key":"292_CR5","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1080\/10428190701824585","volume":"49","author":"S Rajappa","year":"2008","unstructured":"Rajappa S, Varadpande L, Paul T, et al. Imatinib mesylate in early chronic phase chronic myeloid leukemia: experience from a developing country. Leuk Lymphoma. 2008;49:554\u20138. doi: 10.1080\/10428190701824585 .","journal-title":"Leuk Lymphoma"},{"key":"292_CR6","first-page":"2177","volume":"8","author":"HM Kantarjian","year":"2002","unstructured":"Kantarjian HM, Talpaz M, O\u2019Brien S, et al. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results. Clin Cancer Res. 2002;8:2177\u201387.","journal-title":"Clin Cancer Res"},{"key":"292_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12185-008-0111-6","volume":"88","author":"Y Nannya","year":"2008","unstructured":"Nannya Y, Yokota H, Sato Y, et al. Molecular and cytogenetic response of chronic myelogenous leukemia treated with imatinib mesylate: one institutional experience in Japan. Int J Hematol. 2008;88:159\u201364. doi: 10.1007\/s12185-008-0111-6 .","journal-title":"Int J Hematol"},{"key":"292_CR8","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","volume":"108","author":"M Baccarani","year":"2006","unstructured":"Baccarani M, Saglio G, Goldman J, et al. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2006;108:1809\u201320. doi: 10.1182\/blood-2006-02-005686 .","journal-title":"Blood"},{"key":"292_CR9","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3324\/haematol.12033","volume":"92","author":"F Palandri","year":"2007","unstructured":"Palandri F, Iacobucci I, Quarantelli F, et al. Long-term molecular responses to imatinib in patients with chronic myeloid leukemia: comparison between complete cytogenetic responders treated in early and in late chronic phase. Haematologica. 2007;92:1579\u201380. doi: 10.3324\/haematol.12033 .","journal-title":"Haematologica"},{"key":"292_CR10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.18553\/jmcp.2007.13.s8-a.4","volume":"13","author":"J Sessions","year":"2007","unstructured":"Sessions J. Chronic myeloid leukemia in 2007. J Manag Care Pharm. 2007;13:4\u20137.","journal-title":"J Manag Care Pharm"},{"issue":"1","key":"292_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00277-008-0548-y","volume":"88","author":"Y Qin","year":"2009","unstructured":"Qin Y, Jiang B, Jiang Q, et al. Molecular responses of late chronic phase chronic myeloid leukemia patients after achieving complete cytogenetic responses with imatinib treatment: a 6-year follow-up. Ann Hematol. 2009;88(1):37\u201341.","journal-title":"Ann Hematol"},{"key":"292_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0165-4608(91)90248-S","volume":"55","author":"PH Fitzgerald","year":"1991","unstructured":"Fitzgerald PH. Complex Ph translocations in chronic myeloid leukemia. Cancer Genet Cytogenet. 1991;55:129\u201331. doi: 10.1016\/0165-4608(91)90248-S .","journal-title":"Cancer Genet Cytogenet"},{"key":"292_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0165-4608(99)00187-9","volume":"118","author":"KS Reddy","year":"2000","unstructured":"Reddy KS, Sulcova VA. FISH study of variant Philadelphia rearrangements. Cancer Genet Cytogenet. 2000;118:121\u201331. doi: 10.1016\/S0165-4608(99)00187-9 .","journal-title":"Cancer Genet Cytogenet"},{"key":"292_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1046\/j.1365-2141.2003.04291.x","volume":"121","author":"AG Reid","year":"2003","unstructured":"Reid AG, Huntly BJ, Grace C, et al. Survival implications of molecular heterogeneity in variant Philadelphia-positive chronic myeloid leukaemia. Br J Haematol. 2003;121:419\u201327. doi: 10.1046\/j.1365-2141.2003.04291.x .","journal-title":"Br J Haematol"},{"key":"292_CR15","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1182\/blood.V97.11.3581","volume":"97","author":"E Kolomietz","year":"2001","unstructured":"Kolomietz E, Al-Maghrabi J, Brennan S, et al. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood. 2001;97:3581\u20138. doi: 10.1182\/blood.V97.11.3581 .","journal-title":"Blood"},{"key":"292_CR16","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1182\/blood-2007-02-074252","volume":"110","author":"S Kreil","year":"2007","unstructured":"Kreil S, Pfirrmann M, Haferlach C, et al. Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia. Blood. 2007;110:1283\u201390. doi: 10.1182\/blood-2007-02-074252 .","journal-title":"Blood"},{"key":"292_CR17","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/cncr.22936","volume":"110","author":"MW Deininger","year":"2007","unstructured":"Deininger MW, Cortes J, Paquette R, et al. The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells. Cancer. 2007;110:1509\u201319. doi: 10.1002\/cncr.22936 .","journal-title":"Cancer"},{"key":"292_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.0022-202x.2001.00006.x","volume":"6","author":"H Yoshida","year":"2001","unstructured":"Yoshida H, Kunisada T, Grimm T, et al. Review: melanocyte migration and survival controlled by SCF\/c-kit expression. J Investig Dermatol Symp Proc. 2001;6:1\u20135. doi: 10.1046\/j.0022-202x.2001.00006.x .","journal-title":"J Investig Dermatol Symp Proc"},{"key":"292_CR19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(24)38879-2","volume":"295","author":"E Buchdunger","year":"2000","unstructured":"Buchdunger E, Cioffi CL, Law N, et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther. 2000;295:139\u201345.","journal-title":"J Pharmacol Exp Ther"},{"key":"292_CR20","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1002\/cncr.20267","volume":"100","author":"KW Leong","year":"2004","unstructured":"Leong KW, Lee TC, Goh AS. Imatinib mesylate causes hypopigmentation in the skin. Cancer. 2004;100:2486\u20137. doi: 10.1002\/cncr.20267 . author reply 7\u20138.","journal-title":"Cancer"},{"key":"292_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1756-8722-1-15","volume":"1","author":"S Cang","year":"2008","unstructured":"Cang S, Liu D. P-loop mutations and novel therapeutic approaches in imatinib failures in chronic myeloid leukemia. J Hematol Oncol. 2008;1:15.","journal-title":"J Hematol Oncol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0292-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-009-0292-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0292-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0292-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T21:19:59Z","timestamp":1739049599000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-009-0292-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["292"],"URL":"https:\/\/doi.org\/10.1007\/s12185-009-0292-7","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2009,4,7]]}}}